SV

Street Verdict

Analyst Scorecard

A record of what ETMarkets Analysis said publicly, with the source. Not advice.

Pending — not yet graded
“Divi's Laboratories has broken out from a downward-sloping trendline, suggesting potential for upward movement. Medium-term traders are advised to buy the stock with a target above ₹7,000 levels within the next 3-4 months, supported by strong price action, trading above key moving averages, and higher volume during the breakout.”

ETMarkets Analysis’s track record (trackable calls only): 193 graded calls · 95% CI 23–35%

Divi's LaboratoriesBullishCalled 15 Oct 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Tracking Divi's Laboratories since this call

1-year tracking window
Read the original articleSee ETMarkets Analysis’s full track record